Search research articles
Contact Us
Filters
Showing results (151-160 of 163) with videos related to
Page
of 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF
M Engelhard, H Gerhartz, G Brittinger, et al.
Blut
|
March 1, 1988
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy
H H Gerhartz, E Thiel, G Brittinger, et al.
Annals of Hematology
|
December 2, 2000
Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia
M Flasshove, P Meusers, J Schütte, et al.
Blood
|
April 1, 1997
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor
M Engelhard, G Brittinger, D Huhn, et al.
Der Internist
|
January 15, 2003
[Chronic lymphatic leukemia. Current therapy concepts]
M Hallek, M Bergmann, G Brittinger, et al.
The New England Journal of Medicine
|
August 16, 1979
Heterogeneity of diffuse "histiocytic" lymphoma according to the Kiel classification
P Meusers, H Bartels, G Brittinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma
J Lundin, A Osterborg, G Brittinger, et al.
British Journal of Haematology
|
September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group
M Hallek, B Schmitt, M Wilhelm, et al.
Blut
|
September 1, 1981
Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancy
U Schmalhorst, H Bartels, I Boll, et al.
Blut
|
September 1, 1981
Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classification
G Brittinger, U Schmalhorst, H Bartels, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 163) with videos related to
Sort By:
Page
of 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF
M Engelhard, H Gerhartz, G Brittinger, et al.
Blut
|
March 1, 1988
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy
H H Gerhartz, E Thiel, G Brittinger, et al.
Annals of Hematology
|
December 2, 2000
Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia
M Flasshove, P Meusers, J Schütte, et al.
Blood
|
April 1, 1997
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor
M Engelhard, G Brittinger, D Huhn, et al.
Der Internist
|
January 15, 2003
[Chronic lymphatic leukemia. Current therapy concepts]
M Hallek, M Bergmann, G Brittinger, et al.
The New England Journal of Medicine
|
August 16, 1979
Heterogeneity of diffuse "histiocytic" lymphoma according to the Kiel classification
P Meusers, H Bartels, G Brittinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma
J Lundin, A Osterborg, G Brittinger, et al.
British Journal of Haematology
|
September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group
M Hallek, B Schmitt, M Wilhelm, et al.
Blut
|
September 1, 1981
Clinical and prognostic heterogeneity of non-Hodgkin lymphomas of high-grade malignancy
U Schmalhorst, H Bartels, I Boll, et al.
Blut
|
September 1, 1981
Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classification
G Brittinger, U Schmalhorst, H Bartels, et al.
Page
of 17